Go Pro

Robert Burns Analyst Performance

Vice President of Equity Research at HC Wainwright

Robert Burns is a stock analyst at HC Wainwright focused in the healthcare sector, covering 50 publicly traded companies. Over the past year, Robert Burns has issued 143 stock ratings, including buy, hold, and sell recommendations. While full access to Robert Burns' proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Robert Burns' coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
315 Last 6 Years
Buy Recommendations
91.72% 288 Buy Ratings
Companies Covered
50 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.3%1 ratings
Buy91.4%287 ratings
Hold7.6%24 ratings
Sell0.6%2 ratings

Out of 314 total stock ratings issued by Robert Burns at HC Wainwright, the majority (91.4%) have been Buy recommendations, followed by 7.6% Hold, 0.6% Sell, and 0.3% Strong Buy.

Exchange Coverage

ExchangePercentageCount
NASDAQ
92.0% of companies on NASDAQ
46 companies
NYSE
4.0% of companies on NYSE
2 companies
OTCMKTS
2.0% of companies on OTCMKTS
1 company
NYSEAMERICAN
2.0% of companies on NYSEAMERICAN
1 company

Robert Burns, an analyst at HC Wainwright, currently covers 50 companies listed on NASDAQ, NYSE, OTCMKTS and NYSEAMERICAN, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Healthcare
49 companies
98.0%
Miscellaneous
1 company
2.0%

Robert Burns of HC Wainwright specializes in stock coverage within the Healthcare sector, with additional focus on companies.

Coverage Industries

IndustryPercentage
BIOTECHNOLOGY
46 companies
92.0%
PHARMACEUTICALS
3 companies
6.0%
Miscellaneous
1 company
2.0%

About Robert Burns

Mr. Burns is a Vice President of Equity Research at H.C. Wainwright whose research focuses on the biotechnology sector. Mr. Burns’ expertise spans the universe of next-generation approaches to the treatment of cancer, with particular focus on the immuno-oncology and precision oncology sectors. Prior to joining H.C. Wainwright, Mr. Burns worked at BMO Capital Markets as an equity research associate covering Major Pharma under analyst Alex Arfaei; he followed multiple Top 10 pharmaceutical firms and focused on tracking developments in the oncology arena, particularly within the context of checkpoint inhibition and immunotherapy. Mr. Burns’ educational background includes a Master’s degree in Medical Science from Boston University School of Medicine as well as a Bachelor’s degree in Chemistry from Brooklyn College. Mr. Burns also attended Boston University School of Medicine as a medical student for three years.
Follow on LinkedIn

Robert Burns' Ratings History at HC Wainwright

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
PMV Pharmaceuticals, Inc. stock logo
PMVP
PMV Pharmaceuticals
9/4/2026Reiterated Rating$1.24$5.00Buy
Telix Pharmaceuticals Limited stock logo
TLPPF
Telix Pharmaceuticals
9/2/2026Reiterated Rating$11.08Buy
Telix Pharmaceuticals Limited stock logo
TLX
Telix Pharmaceuticals
9/2/2026Reiterated Rating$10.85$20.00Buy
BlossomHill Therapeutics, Inc. stock logo
BLSM
BlossomHill Therapeutics
9/1/2026Initiated Coverage$18.30$35.00Buy
BlossomHill Therapeutics, Inc. stock logo
BLSM
BlossomHill Therapeutics
9/1/2026Initiated Coverage$18.99$35.00Buy
Revolution Medicines, Inc. stock logo
RVMD
Revolution Medicines
8/27/2026Boost Price Target$215.44$280.00Buy
Zymeworks Inc. stock logo
ZYME
Zymeworks
8/26/2026Boost Price Target$27.47$55.00Buy
Inhibrx Biosciences, Inc. stock logo
INBX
Inhibrx Biosciences
8/24/2026Initiated Coverage$103.63$245.00Buy
Relay Therapeutics, Inc. stock logo
RLAY
Relay Therapeutics
8/20/2026Boost Price Target$20.74$29.00Buy
Elicio Therapeutics, Inc. stock logo
ELTX
Elicio Therapeutics
8/18/2026Reiterated Rating$3.02Buy
Tango Therapeutics, Inc. stock logo
TNGX
Tango Therapeutics
8/18/2026Boost Price Target$25.29$68.00Buy
ArriVent BioPharma, Inc. stock logo
AVBP
ArriVent BioPharma
8/17/2026Boost Price Target$29.51$47.00Buy
Cullinan Therapeutics, Inc. stock logo
CGEM
Cullinan Therapeutics
8/17/2026Reiterated Rating$20.34$30.00Buy
Oric Pharmaceuticals, Inc. stock logo
ORIC
Oric Pharmaceuticals
8/10/2026Boost Price Target$13.50$27.00Buy
Immix Biopharma, Inc. stock logo
IMMX
Immix Biopharma
8/10/2026Boost Price Target$9.72$25.00Buy
Zymeworks Inc. stock logo
ZYME
Zymeworks
8/5/2026Boost Price Target$23.56$51.00Buy
Karyopharm Therapeutics Inc. stock logo
KPTI
Karyopharm Therapeutics
7/31/2026Downgrade$7.01Negative
Karyopharm Therapeutics Inc. stock logo
KPTI
Karyopharm Therapeutics
7/31/2026Reiterated Rating$7.01$3.00Neutral
Prelude Therapeutics Incorporated stock logo
PRLD
Prelude Therapeutics
7/29/2026Reiterated Rating$4.64$8.00Buy
Telix Pharmaceuticals Limited stock logo
TLPPF
Telix Pharmaceuticals
7/28/2026Reiterated Rating$10.02Buy
Nuvation Bio Inc. stock logo
NUVB
Nuvation Bio
7/27/2026Boost Price Target$6.45$21.00Buy
OnKure Therapeutics, Inc. stock logo
OKUR
OnKure Therapeutics
7/20/2026Lower Price Target$4.18$21.00Buy
Prelude Therapeutics Incorporated stock logo
PRLD
Prelude Therapeutics
7/15/2026Reiterated Rating$4.39Buy
Nurix Therapeutics, Inc. stock logo
NRIX
Nurix Therapeutics
7/10/2026Boost Price Target$24.69$34.00Buy
Enliven Therapeutics, Inc. stock logo
ELVN
Enliven Therapeutics
7/9/2026Boost Price Target$50.80$64.00Buy
Telix Pharmaceuticals Limited stock logo
TLX
Telix Pharmaceuticals
7/7/2026Reiterated Rating$12.15$20.00Buy
Molecular Partners AG Sponsored ADR stock logo
MOLN
Molecular Partners
7/6/2026Reiterated Rating$3.98Buy
Revolution Medicines, Inc. stock logo
RVMD
Revolution Medicines
7/6/2026Reiterated Rating$190.26$195.00Buy
Exelixis, Inc. stock logo
EXEL
Exelixis
7/2/2026Reiterated Rating$53.96$56.00Buy
Karyopharm Therapeutics Inc. stock logo
KPTI
Karyopharm Therapeutics
6/18/2026Reiterated Rating$9.40Buy
Elicio Therapeutics, Inc. stock logo
ELTX
Elicio Therapeutics
6/15/2026Boost Price Target$14.85$23.00Buy
Nurix Therapeutics, Inc. stock logo
NRIX
Nurix Therapeutics
6/10/2026Reiterated Rating$15.64$32.00Buy
Tango Therapeutics, Inc. stock logo
TNGX
Tango Therapeutics
6/9/2026Boost Price Target$31.12$66.00Buy
ADC Therapeutics SA stock logo
ADCT
ADC Therapeutics
6/8/2026Downgrade$1.03Neutral
Oric Pharmaceuticals, Inc. stock logo
ORIC
Oric Pharmaceuticals
6/8/2026Reiterated Rating$7.50$25.00Buy
Fate Therapeutics, Inc. stock logo
FATE
Fate Therapeutics
6/8/2026Reiterated Rating$1.98$7.00Buy
Cullinan Therapeutics, Inc. stock logo
CGEM
Cullinan Therapeutics
6/8/2026Reiterated Rating$13.51$30.00Buy
Radiopharm Theranostics Limited - Sponsored ADR stock logo
RADX
Radiopharm Theranostics
6/4/2026Initiated Coverage$4.49$6.00Buy
Zymeworks Inc. stock logo
ZYME
Zymeworks
6/3/2026Reiterated Rating$24.11$46.00Buy
Aktis Oncology stock logo
AKTS
Aktis Oncology
6/2/2026Boost Price Target$19.81$35.00Buy
Feds Say Your Cash Isn’t Property—Can They Take It? (Ad)

The Department of Justice recently argued in court that cash may not qualify as legal property. That raises new questions about how protected everyday bank accounts and retirement savings really are.tc pixel

Get the free information kit with 3 strategies to help protect your savings
Revolution Medicines, Inc. stock logo
RVMD
Revolution Medicines
6/1/2026Boost Price Target$163.40$195.00Buy
Cardiff Oncology, Inc. stock logo
CRDF
Cardiff Oncology
6/1/2026Downgrade$1.90Neutral
Elicio Therapeutics, Inc. stock logo
ELTX
Elicio Therapeutics
5/28/2026Reiterated Rating$10.77$17.00Buy
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
5/28/2026Reiterated Rating$5.28$7.00Buy
Relay Therapeutics, Inc. stock logo
RLAY
Relay Therapeutics
5/26/2026Boost Price Target$13.53$28.00Buy
Immix Biopharma, Inc. stock logo
IMMX
Immix Biopharma
5/22/2026Boost Price Target$8.90$20.00Buy
Caribou Biosciences, Inc. stock logo
CRBU
Caribou Biosciences
5/11/2026Boost Price Target$1.94$11.00Buy
Exelixis, Inc. stock logo
EXEL
Exelixis
5/7/2026Boost Price Target$48.70$56.00Buy
Cogent Biosciences, Inc. stock logo
COGT
Cogent Biosciences
5/6/2026Boost Price Target$36.97$55.00Buy
Karyopharm Therapeutics Inc. stock logo
KPTI
Karyopharm Therapeutics
5/6/2026Boost Price Target$9.41$13.00Buy
ADC Therapeutics SA stock logo
ADCT
ADC Therapeutics
5/5/2026Reiterated Rating$3.64$8.00Buy
Nuvation Bio Inc. stock logo
NUVB
Nuvation Bio
5/5/2026Reiterated Rating$4.45$17.00Buy
Fate Therapeutics, Inc. stock logo
FATE
Fate Therapeutics
5/4/2026Boost Price Target$1.53$7.00Buy
Relay Therapeutics, Inc. stock logo
RLAY
Relay Therapeutics
4/29/2026Boost Price Target$13.03$25.00Buy
Black Diamond Therapeutics, Inc. stock logo
BDTX
Black Diamond Therapeutics
4/29/2026Boost Price Target$2.70$11.00Buy
Cullinan Therapeutics, Inc. stock logo
CGEM
Cullinan Therapeutics
4/28/2026Boost Price Target$12.85$30.00Buy
Prelude Therapeutics Incorporated stock logo
PRLD
Prelude Therapeutics
4/27/2026Boost Price Target$4.70$8.00Buy
Nurix Therapeutics, Inc. stock logo
NRIX
Nurix Therapeutics
4/27/2026Reiterated Rating$16.68$32.00Buy
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
4/27/2026Reiterated Rating$105.46$130.00Buy
Revolution Medicines, Inc. stock logo
RVMD
Revolution Medicines
4/22/2026Reiterated Rating$148.90Buy
Molecular Partners AG Sponsored ADR stock logo
MOLN
Molecular Partners
4/22/2026Reiterated Rating$4.49$13.00Buy
Allogene Therapeutics, Inc. stock logo
ALLO
Allogene Therapeutics
4/14/2026Boost Price Target$3.04$12.00Buy
Telix Pharmaceuticals Limited stock logo
TLX
Telix Pharmaceuticals
4/13/2026Reiterated Rating$10.54$20.00Buy
Replimune Group, Inc. stock logo
REPL
Replimune Group
4/13/2026Reiterated Rating$4.77Sell
Nurix Therapeutics, Inc. stock logo
NRIX
Nurix Therapeutics
4/10/2026Reiterated Rating$16.24$32.00Buy
Caribou Biosciences, Inc. stock logo
CRBU
Caribou Biosciences
4/7/2026Reiterated Rating$1.95$9.00Buy
Telix Pharmaceuticals Limited stock logo
TLX
Telix Pharmaceuticals
4/7/2026Reiterated Rating$9.09$20.00Buy
Oric Pharmaceuticals, Inc. stock logo
ORIC
Oric Pharmaceuticals
4/2/2026Reiterated Rating$7.47$25.00Buy
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
3/31/2026Lower Price Target$85.25$130.00Buy
Aktis Oncology stock logo
AKTS
Aktis Oncology
3/31/2026Boost Price Target$16.54$33.00Buy
Bicara Therapeutics Inc. stock logo
BCAX
Bicara Therapeutics
3/31/2026Boost Price Target$19.04$42.00Buy
Immix Biopharma, Inc. stock logo
IMMX
Immix Biopharma
3/27/2026Boost Price Target$8.72$15.00Buy
Enliven Therapeutics, Inc. stock logo
ELVN
Enliven Therapeutics
3/26/2026Boost Price Target$35.53$56.00Buy
Karyopharm Therapeutics Inc. stock logo
KPTI
Karyopharm Therapeutics
3/25/2026Lower Price Target$5.44$8.00Buy
Nurix Therapeutics, Inc. stock logo
NRIX
Nurix Therapeutics
3/24/2026Reiterated Rating$14.69$32.00Buy
Adicet Bio, Inc. stock logo
ACET
Adicet Bio
3/23/2026Lower Price Target$6.92$27.00Buy
Relay Therapeutics, Inc. stock logo
RLAY
Relay Therapeutics
3/23/2026Boost Price Target$9.91$19.00Buy
ADC Therapeutics SA stock logo
ADCT
ADC Therapeutics
3/23/2026Boost Price Target$3.88$8.00Buy
Perspective Therapeutics, Inc. stock logo
CATX
Perspective Therapeutics
3/23/2026Boost Price Target$4.45$13.00Buy
OnKure Therapeutics, Inc. stock logo
OKUR
OnKure Therapeutics
3/16/2026Lower Price Target$3.78$27.00Buy
Molecular Partners AG Sponsored ADR stock logo
MOLN
Molecular Partners
3/16/2026Reiterated Rating$4.22$13.00Buy
Elicio Therapeutics, Inc. stock logo
ELTX
Elicio Therapeutics
3/13/2026Boost Price Target$10.90$17.00Buy
Oric Pharmaceuticals, Inc. stock logo
ORIC
Oric Pharmaceuticals
3/13/2026Reiterated Rating$11.76$25.00Buy
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
3/13/2026Reiterated Rating$4.05$7.00Buy
Aktis Oncology stock logo
AKTS
Aktis Oncology
3/9/2026Initiated Coverage$18.81$30.00Buy
ArriVent BioPharma, Inc. stock logo
AVBP
ArriVent BioPharma
3/6/2026Boost Price Target$25.25$44.00Buy
BridgeBio Oncology Therapeutics, Inc stock logo
BBOT
BridgeBio Oncology Therapeutics
3/6/2026Boost Price Target$9.89$29.00Buy
Tango Therapeutics, Inc. stock logo
TNGX
Tango Therapeutics
3/6/2026Boost Price Target$16.80$27.00Buy
Zymeworks Inc. stock logo
ZYME
Zymeworks
3/6/2026Boost Price Target$24.80$46.00Buy
Oric Pharmaceuticals, Inc. stock logo
ORIC
Oric Pharmaceuticals
2/24/2026Boost Price Target$12.46$25.00Buy
Earth's biggest energy source: near Grand Canyon (Ad)

The largest energy source on Earth contains 50,000 times every oil and gas reserve on the planet combined - and much of it sits beneath the desert near the Grand Canyon. A drilling crew just hit the DOE's 2035 targets twelve years early, with costs down 50% in 18 months. Google signed on, Gates invested, and the Pentagon made it a priority. One company has been quietly building this infrastructure for sixty years.tc pixel

See the company sitting on the biggest energy source on Earth
Karyopharm Therapeutics Inc. stock logo
KPTI
Karyopharm Therapeutics
2/18/2026Reiterated Rating$9.40$15.00Buy
Exelixis, Inc. stock logo
EXEL
Exelixis
2/12/2026Boost Price Target$42.94$54.00Buy
Exelixis, Inc. stock logo
EXEL
Exelixis
2/3/2026Reiterated Rating$42.81$52.00Buy
TuHURA Biosciences, Inc. stock logo
HURA
TuHURA Biosciences
2/3/2026Reiterated Rating$0.52$10.00Buy
Perspective Therapeutics, Inc. stock logo
CATX
Perspective Therapeutics
1/30/2026Boost Price Target$4.26$12.00Buy
Nurix Therapeutics, Inc. stock logo
NRIX
Nurix Therapeutics
1/29/2026Boost Price Target$17.87$32.00Buy
Cardiff Oncology, Inc. stock logo
CRDF
Cardiff Oncology
1/28/2026Reiterated Rating$2.00$10.00Buy
Molecular Partners AG Sponsored ADR stock logo
MOLN
Molecular Partners
1/27/2026Initiated Coverage$4.09$13.00Buy
Exelixis, Inc. stock logo
EXEL
Exelixis
1/27/2026Boost Price Target$43.61$52.00Buy
Molecular Partners AG Sponsored ADR stock logo
MOLN
Molecular Partners
1/27/2026Initiated Coverage$4.00$13.00Buy
Adicet Bio, Inc. stock logo
ACET
Adicet Bio
1/21/2026Reiterated Rating$7.90$50.00Buy
Telix Pharmaceuticals Limited stock logo
TLX
Telix Pharmaceuticals
1/21/2026Reiterated Rating$7.73$20.00Buy
Bicara Therapeutics Inc. stock logo
BCAX
Bicara Therapeutics
1/14/2026Reiterated Rating$17.53Buy
Nuvation Bio Inc. stock logo
NUVB
Nuvation Bio
1/12/2026Lower Price Target$8.03$17.00Buy
TuHURA Biosciences, Inc. stock logo
HURA
TuHURA Biosciences
1/9/2026Reiterated Rating$0.75$10.00Buy
Cullinan Therapeutics, Inc. stock logo
CGEM
Cullinan Therapeutics
1/8/2026Boost Price Target$10.71$27.00Buy
Exelixis, Inc. stock logo
EXEL
Exelixis
1/8/2026Boost Price Target$44.79$52.00Buy
Cogent Biosciences, Inc. stock logo
COGT
Cogent Biosciences
1/6/2026Boost Price Target$34.26$52.00Buy
Telix Pharmaceuticals Limited stock logo
TLX
Telix Pharmaceuticals
12/22/2025Reiterated Rating$7.80$20.00Buy
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
12/11/2025Reiterated Rating$96.00$140.00Buy
Nuvation Bio Inc. stock logo
NUVB
Nuvation Bio
12/11/2025Boost Price Target$7.90$18.00Buy
Nurix Therapeutics, Inc. stock logo
NRIX
Nurix Therapeutics
12/10/2025Boost Price Target$19.55$31.00Buy
Nuvation Bio Inc. stock logo
NUVB
Nuvation Bio
12/1/2025Reiterated Rating$8.05$10.00Buy
Cullinan Therapeutics, Inc. stock logo
CGEM
Cullinan Therapeutics
11/20/2025Boost Price Target$9.10$26.00Buy
Zymeworks Inc. stock logo
ZYME
Zymeworks
11/18/2025Boost Price Target$23.90$32.00Buy
Oric Pharmaceuticals, Inc. stock logo
ORIC
Oric Pharmaceuticals
11/14/2025Boost Price Target$13.08$23.00Buy
Cogent Biosciences, Inc. stock logo
COGT
Cogent Biosciences
11/13/2025Boost Price Target$35.26$50.00Buy
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
11/10/2025Boost Price Target$103.14$140.00Buy
Adicet Bio, Inc. stock logo
ACET
Adicet Bio
11/7/2025Boost Price Target$10.83$144.00Buy
Revolution Medicines, Inc. stock logo
RVMD
Revolution Medicines
11/6/2025Boost Price Target$59.34$73.00Buy
Caribou Biosciences, Inc. stock logo
CRBU
Caribou Biosciences
11/5/2025Boost Price Target$2.17$9.00Buy
Exelixis, Inc. stock logo
EXEL
Exelixis
11/5/2025Boost Price Target$39.06$49.00Buy
Cogent Biosciences, Inc. stock logo
COGT
Cogent Biosciences
11/4/2025Reiterated Rating$15.50$21.00Buy
MacroGenics, Inc. stock logo
MGNX
MacroGenics
11/3/2025Reiterated Rating$1.66$2.00Neutral
Fate Therapeutics, Inc. stock logo
FATE
Fate Therapeutics
10/31/2025Upgrade$1.29$5.00Buy
Zymeworks Inc. stock logo
ZYME
Zymeworks
10/27/2025Reiterated Rating$17.87Buy
Nurix Therapeutics, Inc. stock logo
NRIX
Nurix Therapeutics
10/27/2025Lower Price Target$11.98$28.00Buy
Replimune Group, Inc. stock logo
REPL
Replimune Group
10/27/2025Upgrade$8.80$12.00Buy
Repare Therapeutics Inc. stock logo
RPTX
Repare Therapeutics
10/27/2025Lower Price Target$1.90$3.00Buy
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
10/20/2025Set Price Target$5.74$7.00Buy
Nurix Therapeutics, Inc. stock logo
NRIX
Nurix Therapeutics
10/20/2025Reiterated Rating$9.84$33.00Buy
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
10/20/2025Initiated Coverage$5.86$7.00Buy
ADC Therapeutics SA stock logo
ADCT
ADC Therapeutics
10/16/2025Lower Price Target$4.24$7.00Buy
Nurix Therapeutics, Inc. stock logo
NRIX
Nurix Therapeutics
10/14/2025Lower Price Target$9.72$33.00Buy
Zymeworks Inc. stock logo
ZYME
Zymeworks
10/14/2025Set Price Target$18.11$26.00Buy
Karyopharm Therapeutics Inc. stock logo
KPTI
Karyopharm Therapeutics
10/13/2025Upgrade$5.50$15.00Buy
Perspective Therapeutics, Inc. stock logo
CATX
Perspective Therapeutics
10/3/2025Reiterated Rating$3.49$10.00Buy
Prelude Therapeutics Incorporated stock logo
PRLD
Prelude Therapeutics
9/23/2025Reiterated Rating$1.01$5.00Buy
Nuvation Bio Inc. stock logo
NUVB
Nuvation Bio
9/19/2025Reiterated Rating$3.16$10.00Buy
Perspective Therapeutics, Inc. stock logo
CATX
Perspective Therapeutics
9/19/2025Reiterated Rating$3.29$10.00Buy
The 2026 beginners Guide to Gold IRAs (Ad)

Gold trades near record highs while silver just topped $81 an ounce for the first time ever. Thousands of Americans use Gold IRAs to diversify retirement savings amid rising national debt. The free 2026 Beginner's Guide to Gold IRAs covers top advantages, penalty free 401k rollovers, and simple steps to get started.tc pixel

Download the free Beginner's Guide to Gold IRAs now
Cullinan Therapeutics, Inc. stock logo
CGEM
Cullinan Therapeutics
9/12/2025Reiterated Rating$6.62$24.00Buy
Immix Biopharma, Inc. stock logo
IMMX
Immix Biopharma
9/12/2025Boost Price Target$2.22$8.00Buy
Telix Pharmaceuticals Limited stock logo
TLX
Telix Pharmaceuticals
9/10/2025Lower Price Target$9.66$20.00Buy
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
9/8/2025Reiterated Rating$112.46$136.00Buy
Replimune Group, Inc. stock logo
REPL
Replimune Group
9/8/2025Reiterated Rating$6.33Neutral
Relay Therapeutics, Inc. stock logo
RLAY
Relay Therapeutics
8/26/2025Lower Price Target$3.51$14.00Buy
OnKure Therapeutics, Inc. stock logo
OKUR
OnKure Therapeutics
8/26/2025Reiterated Rating$2.75$34.00Buy
Bicara Therapeutics Inc. stock logo
BCAX
Bicara Therapeutics
8/22/2025Lower Price Target$11.63$40.00Buy
Cullinan Therapeutics, Inc. stock logo
CGEM
Cullinan Therapeutics
8/21/2025Initiated Coverage$7.47$24.00Buy
Oric Pharmaceuticals, Inc. stock logo
ORIC
Oric Pharmaceuticals
8/14/2025Lower Price Target$9.83$19.00Buy
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
8/14/2025Lower Price Target$111.87$136.00Buy
ArriVent BioPharma, Inc. stock logo
AVBP
ArriVent BioPharma
8/12/2025Reiterated Rating$17.42$42.00Buy
Exelixis, Inc. stock logo
EXEL
Exelixis
8/12/2025Lower Price Target$37.41$46.00Buy
Black Diamond Therapeutics, Inc. stock logo
BDTX
Black Diamond Therapeutics
8/11/2025Lower Price Target$2.40$10.00Buy
Y-mAbs Therapeutics, Inc. stock logo
YMAB
Y-mAbs Therapeutics
8/6/2025Reiterated Rating$8.52$8.60Neutral
Cogent Biosciences, Inc. stock logo
COGT
Cogent Biosciences
8/6/2025Lower Price Target$11.36$21.00Buy
Cardiff Oncology, Inc. stock logo
CRDF
Cardiff Oncology
8/6/2025Lower Price Target$2.57$10.00Buy
Replimune Group, Inc. stock logo
REPL
Replimune Group
7/23/2025Downgrade$2.81Neutral
Adicet Bio, Inc. stock logo
ACET
Adicet Bio
7/23/2025Upgrade$12.03$64.00Strong-Buy
ArriVent BioPharma, Inc. stock logo
AVBP
ArriVent BioPharma
7/22/2025Reiterated Rating$21.55$40.00Buy
Elicio Therapeutics, Inc. stock logo
ELTX
Elicio Therapeutics
7/17/2025Boost Price Target$9.05$13.00Buy
Karyopharm Therapeutics Inc. stock logo
KPTI
Karyopharm Therapeutics
7/16/2025Downgrade$4.24Neutral
Nurix Therapeutics, Inc. stock logo
NRIX
Nurix Therapeutics
7/14/2025Lower Price Target$12.42$34.00Buy
Karyopharm Therapeutics Inc. stock logo
KPTI
Karyopharm Therapeutics
7/11/2025Initiated Coverage$5.00$27.00Buy
Cogent Biosciences, Inc. stock logo
COGT
Cogent Biosciences
7/8/2025Boost Price Target$9.33$22.00Buy
Telix Pharmaceuticals Limited stock logo
TLX
Telix Pharmaceuticals
7/3/2025Initiated Coverage$16.50$23.00Buy
Zymeworks Inc. stock logo
ZYME
Zymeworks
7/3/2025Reiterated Rating$12.89$13.00Neutral
Replimune Group, Inc. stock logo
REPL
Replimune Group
7/3/2025Reiterated Rating$9.55$22.00Buy
Enliven Therapeutics, Inc. stock logo
ELVN
Enliven Therapeutics
7/2/2025Boost Price Target$19.65$48.00Buy
Exelixis, Inc. stock logo
EXEL
Exelixis
6/30/2025Boost Price Target$43.67$53.00Buy
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
6/25/2025Reiterated Rating$105.09$138.00Buy
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
6/16/2025Lower Price Target$106.57$138.00Buy
Exelixis, Inc. stock logo
EXEL
Exelixis
6/12/2025Reiterated Rating$41.43$47.00Buy
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
6/5/2025Boost Price Target$111.21$145.00Buy
Immix Biopharma, Inc. stock logo
IMMX
Immix Biopharma
6/4/2025Reiterated Rating$2.11$7.00Buy
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
5/22/2025Reiterated Rating$99.09$134.00Buy
Cogent Biosciences, Inc. stock logo
COGT
Cogent Biosciences
5/20/2025Lower Price Target$5.03$12.00Buy
Y-mAbs Therapeutics, Inc. stock logo
YMAB
Y-mAbs Therapeutics
5/19/2025Lower Price Target$4.10$11.00Buy
Enliven Therapeutics, Inc. stock logo
ELVN
Enliven Therapeutics
5/15/2025Boost Price Target$19.89$40.00Buy
Revolution Medicines, Inc. stock logo
RVMD
Revolution Medicines
5/14/2025Reiterated Rating$40.01$72.00Buy
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
5/14/2025Reiterated Rating$93.89$134.00Buy
ArriVent BioPharma, Inc. stock logo
AVBP
ArriVent BioPharma
5/14/2025Boost Price Target$18.76$40.00Buy
Cardiff Oncology, Inc. stock logo
CRDF
Cardiff Oncology
5/9/2025Boost Price Target$2.63$18.00Buy
Oric Pharmaceuticals, Inc. stock logo
ORIC
Oric Pharmaceuticals
5/5/2025Reiterated Rating$5.67$21.00Buy
Prelude Therapeutics Incorporated stock logo
PRLD
Prelude Therapeutics
5/5/2025Reiterated Rating$0.89$5.00Buy
Caribou Biosciences, Inc. stock logo
CRBU
Caribou Biosciences
4/28/2025Reiterated Rating$0.77$3.00Buy
Tango Therapeutics, Inc. stock logo
TNGX
Tango Therapeutics
4/14/2025Reiterated Rating$1.41$13.00Buy
Prelude Therapeutics Incorporated stock logo
PRLD
Prelude Therapeutics
4/8/2025Reiterated Rating$0.65$5.00Buy
Elicio Therapeutics, Inc. stock logo
ELTX
Elicio Therapeutics
4/2/2025Reiterated Rating$4.95$10.00Buy
Nurix Therapeutics, Inc. stock logo
NRIX
Nurix Therapeutics
4/2/2025Reiterated Rating$10.47$36.00Buy
Man who Predicted Trump 2016 Win: “Prepare for Mid-Term Meltdown” (Ad)

In 2016, major election models gave Hillary Clinton a 99% chance of winning - but former CIA and Pentagon adviser Jim Rickards publicly predicted a Trump victory before election night. Now Rickards is issuing a new forecast he calls a potential mid-term meltdown, one he believes could send shockwaves through financial markets.tc pixel

See Jim Rickards' full market warning and what it means for your portfolio
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
4/1/2025Lower Price Target$91.06$145.00Buy
ADC Therapeutics SA stock logo
ADCT
ADC Therapeutics
3/31/2025Reiterated Rating$1.49$8.00Buy
Exelixis, Inc. stock logo
EXEL
Exelixis
3/27/2025Reiterated Rating$37.01$40.00Buy
MacroGenics, Inc. stock logo
MGNX
MacroGenics
3/25/2025Lower Price Target$1.96$2.00Neutral
Enliven Therapeutics, Inc. stock logo
ELVN
Enliven Therapeutics
3/21/2025Boost Price Target$20.92$39.00Buy
Y-mAbs Therapeutics, Inc. stock logo
YMAB
Y-mAbs Therapeutics
3/21/2025Lower Price Target$4.92$12.00Buy
PMV Pharmaceuticals, Inc. stock logo
PMVP
PMV Pharmaceuticals
3/20/2025Reiterated Rating$1.28$5.00Buy
Allogene Therapeutics, Inc. stock logo
ALLO
Allogene Therapeutics
3/19/2025Lower Price Target$1.69$8.00Buy
Caribou Biosciences, Inc. stock logo
CRBU
Caribou Biosciences
3/19/2025Reiterated Rating$0.95$9.00Buy
Black Diamond Therapeutics, Inc. stock logo
BDTX
Black Diamond Therapeutics
3/18/2025Boost Price Target$1.71$12.00Buy
Perspective Therapeutics, Inc. stock logo
CATX
Perspective Therapeutics
3/13/2025Initiated Coverage$2.66$10.00Buy
Nuvation Bio Inc. stock logo
NUVB
Nuvation Bio
3/10/2025Lower Price Target$2.03$10.00Buy
Zymeworks Inc. stock logo
ZYME
Zymeworks
3/10/2025Boost Price Target$11.09$13.00Neutral
Repare Therapeutics Inc. stock logo
RPTX
Repare Therapeutics
3/7/2025Lower Price Target$1.19$5.00Buy
Relay Therapeutics, Inc. stock logo
RLAY
Relay Therapeutics
3/7/2025Reiterated Rating$3.48$16.00Buy
ArriVent BioPharma, Inc. stock logo
AVBP
ArriVent BioPharma
3/7/2025Reiterated Rating$21.81$39.00Buy
TuHURA Biosciences, Inc. stock logo
HURA
TuHURA Biosciences
3/3/2025Initiated Coverage$2.41$13.00Buy
Revolution Medicines, Inc. stock logo
RVMD
Revolution Medicines
3/3/2025Boost Price Target$40.74$73.00Buy
Cardiff Oncology, Inc. stock logo
CRDF
Cardiff Oncology
2/28/2025Boost Price Target$4.06$17.00Buy
Oric Pharmaceuticals, Inc. stock logo
ORIC
Oric Pharmaceuticals
2/21/2025Reiterated Rating$7.63$21.00Buy
Exelixis, Inc. stock logo
EXEL
Exelixis
2/13/2025Reiterated Rating$32.80$40.00Buy
Replimune Group, Inc. stock logo
REPL
Replimune Group
2/13/2025Boost Price Target$13.79$22.00Buy
Oric Pharmaceuticals, Inc. stock logo
ORIC
Oric Pharmaceuticals
2/11/2025Reiterated Rating$11.23$21.00Buy
Immix Biopharma, Inc. stock logo
IMMX
Immix Biopharma
2/10/2025Reiterated Rating$2.01$7.00Buy
Nurix Therapeutics, Inc. stock logo
NRIX
Nurix Therapeutics
1/29/2025Boost Price Target$19.56$36.00Buy
Atara Biotherapeutics, Inc. stock logo
ATRA
Atara Biotherapeutics
1/28/2025Reiterated Rating$7.37Neutral
Exelixis, Inc. stock logo
EXEL
Exelixis
1/27/2025Reiterated Rating$32.38$40.00Buy
Nuvation Bio Inc. stock logo
NUVB
Nuvation Bio
1/23/2025Boost Price Target$2.65$11.00Buy
Atara Biotherapeutics, Inc. stock logo
ATRA
Atara Biotherapeutics
1/22/2025Reiterated Rating$6.05Neutral
ArriVent BioPharma, Inc. stock logo
AVBP
ArriVent BioPharma
1/22/2025Boost Price Target$25.31$39.00Buy
Replimune Group, Inc. stock logo
REPL
Replimune Group
1/22/2025Boost Price Target$11.85$21.00Buy
Cogent Biosciences, Inc. stock logo
COGT
Cogent Biosciences
1/14/2025Lower Price Target$7.57$14.00Buy
Relay Therapeutics, Inc. stock logo
RLAY
Relay Therapeutics
1/14/2025Reiterated Rating$4.78$16.00Buy
Y-mAbs Therapeutics, Inc. stock logo
YMAB
Y-mAbs Therapeutics
1/13/2025Reiterated Rating$6.89$22.00Buy
Oric Pharmaceuticals, Inc. stock logo
ORIC
Oric Pharmaceuticals
1/13/2025Reiterated Rating$8.29$21.00Buy
Exelixis, Inc. stock logo
EXEL
Exelixis
1/10/2025Boost Price Target$34.50$40.00Buy